Hester Bios

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
1,867.45
-12.45 (-0.66%)
BSENSE

May 22

BSE+NSE Vol: 18.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sakar Healthcare
Venus Remedies
Fredun Pharma
NGL Fine Chem
Lincoln Pharma.
Amrutanjan Healt
Hester Bios
Windlas Biotech
Solara Active
Jagsonpal Pharma
Indoco Remedies

Why is Hester Biosciences Ltd ?

1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.25 times
  • Poor long term growth as Net Sales has grown by an annual rate of 9.19% and Operating profit at 4.14% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.25 times
  • The company has been able to generate a Return on Capital Employed (avg) of 8.56% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 9.19% and Operating profit at 4.14% over the last 5 years
3
With ROCE of 12.4, it has a Very Expensive valuation with a 3.3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 6.45%, its profits have risen by 95.3% ; the PEG ratio of the company is 0.3
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hester Bios for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Hester Bios
6.45%
0.18
35.37%
Sensex
-6.84%
-0.53
12.96%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.19%
EBIT Growth (5y)
4.14%
EBIT to Interest (avg)
5.08
Debt to EBITDA (avg)
3.94
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
0.55
Tax Ratio
24.20%
Dividend Payout Ratio
21.66%
Pledged Shares
0
Institutional Holding
0.38%
ROCE (avg)
8.83%
ROE (avg)
10.95%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
30
Industry P/E
35
Price to Book Value
4.43
EV to EBIT
26.32
EV to EBITDA
20.59
EV to Capital Employed
3.25
EV to Sales
5.36
PEG Ratio
0.31
Dividend Yield
0.37%
ROCE (Latest)
12.36%
ROE (Latest)
14.91%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
PAT(9M)

At Rs 37.26 cr has Grown at 76.17%

ROCE(HY)

Highest at 15.11%

DEBT-EQUITY RATIO(HY)

Lowest at 0.54 times

NET SALES(Q)

At Rs 100.11 cr has Grown at 22.19%

PBDIT(Q)

Highest at Rs 34.33 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 34.29%

PBT LESS OI(Q)

Highest at Rs 25.18 cr.

-10What is not working for the Company
INTEREST(9M)

At Rs 9.13 cr has Grown at 152.21%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 6.54 cr

Loading Valuation Snapshot...

Here's what is working for Hester Bios

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 25.18 cr has Grown at 135.33%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 14.04 cr has Grown at 988.4%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.54 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Sales - Quarterly
Highest at Rs 100.11 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 100.11 cr has Grown at 22.19%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 34.33 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 34.29%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 25.18 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Hester Bios

Interest - Quarterly
At Rs 5.10 cr has Grown at 180.22%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 6.54 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents